Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Arginase inhibitor combination therapies

Arginase inhibitor combination therapies

US Patent 11291674 · Granted Apr 5, 2022

Estimated economic value: $854,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination therapy with glutaminase inhibitors and immuno-oncology agents2021
Combination therapy with glutaminase inhibitors and immuno-oncology agents2021
Compositions and methods for inhibiting arginase activity2021
Treatment of lung cancer with inhibitors of glutaminase2019
Compositions and methods for inhibiting arginase activity2019
Methods for treating tumors in situ including intratumor injection of cytotoxic 2019
Combination therapy with glutaminase inhibitors2019
Combination therapy with glutaminase inhibitors and immuno-oncology agents2019
Combination therapy with glutaminase inhibitors and immuno-oncology agents2019
Combination therapy with glutaminase inhibitors2019
Compositions and methods for inhibiting arginase activity2018
Fused pyrimidines as inhibitors of P97 complex2018